Bioequivalence Study of Sulfadoxine/ Pyrimethamine Tablets in Healthy Subjects Under Fasting Conditions

NCT04577469 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioequivalence

Interventions

DRUG: Maldox tablets
DRUG: G-COSPE® tablets

Sponsor

Emzor Pharmaceutical Industries Limited